Amyloid precursor protein (APP) is a type I membrane protein with several human isoforms due to alternative splicing. APP-770, -751, and -733 contain a Kunitz protease inhibitor (KPI) domain (residue 291-342) and APP-695 does not. APP is a cell surface molecule with many functions. It can be processed proteolytically in two different pathways. In one pathway, beta - and gamma -secretase cleave at the beta site between residue 670 and 671 and the gamma site between residue 711 and 714 to produce beta ‑amyloid peptide (A beta 40 and A beta 42), a major component in plaques found in brains of patients with Alzheimer's disease (1). The other pathway involves alpha -secretase that cleaves residues between 687 and 688. It is antiamyloidogenic due to its benign character and the prevention of the A beta peptide formation (2). Soluble APP containing the KPI domain, also referred to as protease nexin II, is a potent inhibitor of serine proteases and may have additional functions. For example, it may regulate the contact face of blood coagulation and limit thrombosis specially in brain due to its localization and coagulation factor XI inhibiting activity (3, 4).
Recombinant Human APP/Protease Nexin II Protein, CF
R&D Systems | Catalog # 3466-PI
Loading...
Key Product Details
- R&D Systems NS0-derived Recombinant Human APP/Protease Nexin II Protein (3466-PI)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
NS0
Accession Number
Applications
Inhibition Activity
Loading...
Product Specifications
Source
Mouse myeloma cell line, NS0-derived human APP protein
Leu18-Leu688, with a C-terminal 6-His tag
Leu18-Leu688, with a C-terminal 6-His tag
Purity
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Leu18
Predicted Molecular Mass
77 kDa
SDS-PAGE
120 kDa, reducing conditions
Activity
Measured by its ability to inhibit trypsin cleavage of a fluorogenic peptide substrate, Mca-RPKPVE-Nval-WRK(Dnp)-NH2 (Catalog # ES002).
The IC50 value is <1.2 nM, as measured with under the described conditions.
The IC50 value is <1.2 nM, as measured with under the described conditions.
Formulation, Preparation, and Storage
3466-PI
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 200 μg/mL in sterile, deionized water.
Loading...
|
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Calculators
Background: APP
References
- Haass, C. (2004) EMBO J. 23:483.
- Lichtenthaler, S. F. and C. Haass (2004) J. Clin. Invest. 113:1384.
- Badellino, K.O. and P.N. Walsh (2000) Biochemistry 39:4769.
- Xu, F. et al. (2005) Proc. Natl. Acad. Sci USA. 102:18135.
Long Name
Amyloid Precursor Protein
Alternate Names
Amyloid beta, beta Amyloid, Protease Nexin II
Gene Symbol
APP
UniProt
Additional APP Products
Product Documents for Recombinant Human APP/Protease Nexin II Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Human APP/Protease Nexin II Protein, CF
For research use only
Related Research Areas
Citations for Recombinant Human APP/Protease Nexin II Protein, CF
Powered by Bioz
Customer Reviews for Recombinant Human APP/Protease Nexin II Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human APP/Protease Nexin II Protein, CF and earn rewards!
Have you used Recombinant Human APP/Protease Nexin II Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Recombinant Human APP/Protease Nexin II Protein, CF (3466-PI):
Materials
- Assay Buffer: 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, 0.05% Brij-35, pH 7.5 (TCNB)
- Recombinant Human APP/Protease Nexin II (rhAPP) (Catalog # 3466-PI)
- Trypsin (Sigma, Catalog # T-1426)
- Fluorogenic peptide substrate: MCA-Arg-Pro-Lys-Pro-Val-Glu-NVAL-Trp-Arg-Lys(DNP)-NH2 (Catalog # ES002)
- F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
- Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
- Dilute Trypsin to 0.400 μg/mL in Assay Buffer.
- Prepare a curve of rhAPP-770 (MW: 76,875 Da) in Assay Buffer. Make the following serial dilutions: 100, 20, 10, 5, 3.33, 2.22, 1.11 and 0.370 nM.
- For each reaction tube mix 20 μL of the diluted Trypsin, 100 μL of the rhAPP curve, and 80 μL of TCNB for a final volume of 200 μL. Include a control (in duplicate) containing 180 μL of Assay Buffer and 20 μL of the diluted Trypsin.
- Incubate mixtures at room temperature for 30 minutes.
- Dilute substrate to 20 μM in Assay Buffer.
- Load in a black well plate 50 μL of the reactions, and start the reaction by adding 50 μL of 20 μM substrate.
Read at excitation and emission wavelengths of 320 nm and 405 nm (top read), respectively, in kinetic mode for 5 minutes. - Derive the 50% inhibiting concentration (IC50) value for rhAPP by plotting RFU/min (or specific activity) vs. concentration with 4‑PL fitting.
- The specific activity for Trypsin at each point may be determined using the following formula (if needed):
|
Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) |
| amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Derived using calibration standard MCA-Pro-Leu-OH (Bachem, Catalog # M-1975).
Per Well:
- Trypsin: 0.002 μg
- rhAPP curve: 25, 5, 2.5, 1.25, 0.833, 0.555, 0.2775 and 0.0925 nM
- Substrate: 10 μM
